Kiran Munne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kiran Munne has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Shahina Begum
Department of Biostatistics and Socio Behavioral Research, Indian Council of Medical Research (ICMR) - National Institute for Research on Women’s Health (NIRWoH) [formerly National Institute for Research in Reproductive and Child Health (NIRRCH)], Parel, Mumbai, India
2 shared publications - Vikrant Madhukar Bhor
Department of Molecular Immunology and Microbiology, ICMR-National Institute for Research on Women's Health (NIRWoH), Mumbai, Maharashtra, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
2 shared publications - Aarya Suryawanshi
Viral Immunopathogenesis Lab, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India
1 shared publication Abhijit Kadam
ICMR-National AIDS Research Institute (NARI)
1 shared publication- Amit Kumar Singh
Viral Immunopathogenesis Lab, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India
1 shared publication Anoop Kumar Puri
Ministry of Health & Family Welfare, National AIDS Control Organisation (NACO)
1 shared publication
Latest Publications
- 15 October 2026
- Published by Taylor & Francis in Journal of HIV & Social Services
- p. 1-17
Understanding Knowledge Gaps and Challenges in Antiretroviral Adherence Among People Living with HIV in India: A qualitative investigation
In 2023, an estimated 2.54 million people were living with HIV (PLHIV) in India, with the national adult HIV prevalence rate standing at 0.20%. Despite this relatively low prevalence, India ranks s...
- 15 October 2026
- Published by Taylor & Francis in Journal of HIV & Social Services
- p. 1-17
Understanding Knowledge Gaps and Challenges in Antiretroviral Adherence Among People Living with HIV in India: A qualitative investigation
In 2023, an estimated 2.54 million people were living with HIV (PLHIV) in India, with the national adult HIV prevalence rate standing at 0.20%. Despite this relatively low prevalence, India ranks s...
- Open Access
Protective Immune Signatures Associated with Latent TB Infection in PLHIV—Insights from an Integrative Prospective Immune Monitoring Study
Understanding how HIV-1 pathogenesis affects systemic and TB specific immunity in the setting of latent (LTBI+) compared to active TB infection could provide actionable insights for the prevention of reactivation. Fifty HIV-seronegative and 112 HIV-1-positive anti-retroviral therapy (ART)-naïve participants were stratified as LTBI+ (n = 35), active TB+ (n = 22) and non-coinfected (n = 55) based on an interferon gamma release assay (IGRA) and clinical confirmation prior to receiving TB therapy. Systemic and TB-specific (DosR and Rpf) immune monitoring of cellular subsets, together with multi-analyte plasma analysis, was carried out. Pursuant to isoniazid prophylaxis therapy (IPT) and ART initiation, HIV-1-positive LTBI+ participants (HLTBI+) were followed for up to two years. Before ART initiation, HLTBI+ individuals exhibited the lowest levels of circulating intermediate monocytes, T-cell activation and PD-1 expression, with a decreased frequency of T-regulatory cells and higher circulating IL-10 and IL-17A. PD-1 expression on CD4+ T cell memory subsets, together with opposing anamnestic TNF-α responses to DosR and Rpf, was a discriminatory signature for the HLTBI+ group, as was preserved (following ART) TB-specific TNF-α production, which positively correlated with the CD4/CD8 ratio. Our results highlight an immunomodulatory phenotype conferred by latent TB infection in PLHIV, whose preservation may provide strategies to mitigate TB reactivation.
Open AccessProtective Immune Signatures Associated with Latent TB Infection in PLHIV—Insights from an Integrative Prospective Immune Monitoring Study
Understanding how HIV-1 pathogenesis affects systemic and TB specific immunity in the setting of latent (LTBI+) compared to active TB infection could provide actionable insights for the prevention of reactivation. Fifty HIV-seronegative and 112 HIV-1-positive anti-retroviral therapy (ART)-naïve participants were stratified as LTBI+ (n = 35), active TB+ (n = 22) and non-coinfected (n = 55) based on an interferon gamma release assay (IGRA) and clinical confirmation prior to receiving TB therapy. Systemic and TB-specific (DosR and Rpf) immune monitoring of cellular subsets, together with multi-analyte plasma analysis, was carried out. Pursuant to isoniazid prophylaxis therapy (IPT) and ART initiation, HIV-1-positive LTBI+ participants (HLTBI+) were followed for up to two years. Before ART initiation, HLTBI+ individuals exhibited the lowest levels of circulating intermediate monocytes, T-cell activation and PD-1 expression, with a decreased frequency of T-regulatory cells and higher circulating IL-10 and IL-17A. PD-1 expression on CD4+ T cell memory subsets, together with opposing anamnestic TNF-α responses to DosR and Rpf, was a discriminatory signature for the HLTBI+ group, as was preserved (following ART) TB-specific TNF-α production, which positively correlated with the CD4/CD8 ratio. Our results highlight an immunomodulatory phenotype conferred by latent TB infection in PLHIV, whose preservation may provide strategies to mitigate TB reactivation.
- 6 June 2023
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 45, 100393
Mapping the vaginal microbiota variations in women from a community clinic in Mumbai, India
- 6 June 2023
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 45, 100393
Mapping the vaginal microbiota variations in women from a community clinic in Mumbai, India